[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
January 1955

TREATMENT OF VITILIGO WITH PSORALEN DERIVATIVES

Author Affiliations

New Orleans

AMA Arch Derm. 1955;71(1):14-18. doi:10.1001/archderm.1955.01540250016004
Abstract

COSMETIC disfiguration and psychologic sequelae constitute a serious problem for the patient with vitiligo. Reported successful treatment of this condition with the psoralen derivatives has stimulated considerable interest among physicians, but the frequent occurrence of undesirable side effects from local and oral application has discouraged their use. Despite careful local application of the drug, vesiculation and edema of the involved areas often develop before pigmentation occurs, and oral ingestion also is frequently associated with nausea and other gastrointestinal disturbances. The present clinical study was undertaken in an attempt to find an effective but safe treatment for vitiligo with the psoralen derivatives without undesirable side-effects.

Psoralen derivatives are crystalline principles extracted from the Ammi majus Linn. fruits, found so abundantly in the Nile Delta. Since the 13th century Egyptians have used a powder prepared from the fruit of this plant for treatment of vitiligo. The crude

References
1.
References 4 to 7.
2.
Supplied through the courtesy of Mrs. Louise Otten, Director, Pharmaceutical Division, Bioproducts, Oreg. Ltd., Warrenton, Ore.
3.
References 1, 2, 9, and 10.
4.
Lubafax, a brand of surgical lubricant (Burroughs Wellcome & Company, Inc.), Ingredients: alginate, glycerin, water with o-chloromercuriphenol as preservative.
5.
References 13 to 21.
6.
References 11 and 22 to 24.
7.
Fahmy, I. R., and Abu-Shady, H.:  Ammi Majus Linn: Pharmacognostical Study of Isolation of a Crystalline Constituent, Ammoidin ,  Quart. J. Pharm. & Pharmacol. 20:281, 1947.
8.
Lerner, A. B.; Denton, R. D., and Fitzpatrick, T. B.:  Clinical and Experimental Studies with 8-Methoxypsoralen ,  J. Invest. Dermat. 20:299 ( (April) ) 1953.
9.
El-Mofty, A.-M.:  Preliminary Clinical Report on Treatment of Leucodermia with Ammi Majus Linn ,  J. Roy. Egyptian M. A. 31:651 ( (Aug.) ) 1948.
10.
Sekla, M.:  Treatment of Vitiligo, Correspondence ,  A. M. A. Arch. Dermat. & Syph. 65: 358 ( (March) ) 1952.
11.
Sidi, E., and Bourgeois-Gavardin, J.:  A New Treatment for Vitiligo ,  Presse méd. 60:421 ( (March 26) ) 1952.
12.
Tzanck, A.; Sidi, E., and Bourgeois-Gavardin, J.:  Treatment of Vitiligo with Ammi Majus (Linn.) ,  Bull. et mém. Soc. méd. hôp. Paris 67: 1400 ( (May) ) 1951.
13.
Sidi, E., and Bourgeois-Gavardin, J.:  The Treatment of Vitiligo with Ammi Majus Linn. ,  J. Invest. Dermat. 18:391 ( (May) ) 1952.
14.
El-Mofty, A.-M.:  Observations on Use of Ammi Majus Linn. in Vitiligo ,  Brit. J. Dermat. 64:431 ( (Dec.) ) 1952.
15.
El-Mofty, A.-M.:  Further Studies on the Treatment of Leucodermia with Ammi Majus Linn. ,  J. Roy. Egyptian M. A. 35:1 ( (March) ) 1952.
16.
Elwi, A. M.:  Report on Pathological Lesions Resulting from Administration of Xanthotoxine and Imperatorin to Guinea Pigs ,  J. Roy. Egyptian M. A. 33:773 ( (June) ) 1950.
17.
Wolf, J.: Vitiligo;  Response to ``Meladinin,'' Society Transactions, Chicago Dermatological Society, April 16, 1952 , in  A. M. A. Arch. Dermat. & Syph. 67:333 ( (Feb.) ) 1953.
18.
Wheeler, C. E.; Cawley, E. P., and Curtis, A. C.:  Effect of Topically Applied Hormones on Growth, Pigmentation and Keratinization of the Nipple and Areola ,  J. Invest. Dermat. 20:385 ( (May) ) 1953.
19.
Lerner, A. B., and Fitzpatrick, T. B.:  Biochemistry of Melanin Formation ,  Physiol. Rev. 30: 91, 1950.
20.
Lerner, A. B.; Fitzpatrick, T. B.; Calkins, E., and Summerson, W. H.:  Mammalian Tyrosinase: Relationship of Copper to Enzymatic Activity ,  J. Biol. Chem. 187:793 ( (Dec.) ) 1950.
21.
duBuy, H. G.; Woods, M. W.; Burk, D., and Lackey, M. D.:  Enzymatic Activities of Isolated Amelanotic and Melanotic Granules of Mouse Melanomas and a Suggested Relationship to Mitochondria ,  J. Nat. Cancer Inst. 9:325 ( (Feb.) ) 1949.
22.
Becker, S. W., Jr.; Fitzpatrick, T. B., and Montgomery, H.:  Human Melanogenesis: Cytology and Histology of Pigment Cells (Melanodendrocytes) ,  A. M. A. Arch. Dermat. & Syph. 65:511 ( (May) ) 1952.
23.
Liebertrau, H. R.:  Studien zum Problem der Pigmentbildung in der Haut ,  Dermatologica 103: 75, 1951
24.
abstracted,  Excerpta Med. XIII 6:131, 1952.
25.
Fitzpatrick, T. B.; Becker, S. W., Jr.; Lerner, A. B., and Montgomery, H.:  Tyrosinase in Human Skin: Demonstration of Its Presence and of Its Role in Human Melanin Formation ,  Science 112:223 ( (Aug.) ) 1950.
26.
Fitzpatrick, T. B.; Lerner, A. B.; Calkins, E., and Summerson, W. H.:  Mammalian Tyrosinase: Melanin Formation by Ultraviolet Irradiation ,  Arch. Dermat. & Syph. 59:620 ( (June) ) 1949.
27.
Fitzpatrick, T. B.:  Human Melanogenesis ,  A. M. A. Arch. Dermat. & Syph. 65:379 ( (April) ) 1952.
28.
Fitzpatrick, T. B., and Lerner, A. B.:  Biochemical Basis of Human Melanin Pigmentation ,  A. M. A. Arch. Dermat. & Syph. 69:133 ( (Feb.) ) 1954.
29.
Minor, I.:  Les Affections Pigmentaires de la Peau , abstracted  Excerpta Med. XIII 6:342, 1952.
30.
Lewin, M. L., and Peck, S. M.:  Pigment Studies in Skin Grafts on Experimental Animals ,  J. Invest. Dermat. 4:483, 1941.
31.
Haxthausen, H.:  Studies on Pathogenesis of Morphea, Vitiligo and Acrodermatitis Atrophicans by Means of Transplantation Experiments ,  Acta dermat.-venereol. 27:352 ( (Sept.) ) 1947.
×